Lenvatinib plus pembrolizumab for advanced kidney cancer
The final survival information from the phase 3 CLEAR study [...]
Patient’s perspective on pembrolizumab/lenvatinib for kidney cancer
In 2009, Cesar Fuentes was first diagnosed with kidney cancer [...]
METEOR study: Cabozantinib compared to everolimus in advanced kidney cancer
Cabozantinib is a tyrosine kinase inhibitor that is used [...]
‘No stupid questions’ for newly diagnosed kidney cancer patients
In this recent video interview, Dr Rachel Giles, chief executive [...]
Cancer signs on urinal mats in pubs and football grounds
The NHS are putting urinal mats in public places in [...]
Belzutifan for advanced kidney cancer: long-term follow-up
Studies looking at the genes of people with kidney cancer have shown [...]
ESMO 2023: New online educational programme for kidney cancer nurses
Action Kidney Cancer have been involved with the development of [...]
Artificial intelligence has potential to improve urology services
There has been growing interest around the use artificial intelligence [...]
New treatment, zanzalintinib, for advanced kidney cancer
A recent clinical trial looked at a new anti-cancer medication [...]
Real world treatment of advanced kidney cancer
Nearly 30% of new kidney cancer cases are diagnosed at [...]
